Empagliflozin 25mg is primarily prescribed for managing type 2 diabetes mellitus. Acting as an inhibitor of sodium-glucose cotransporter-2 (SGLT2), it aids in lowering blood sugar levels by facilitating the removal of glucose from the bloodstream through urine. Additionally, it may contribute to reducing